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Purpose: The aim of this study was to investigate the associations of Bethesda categories III, 
V, and VI with the clinical and pathological features of thyroid nodules surgically confirmed as 
conventional papillary thyroid carcinomas (PTCs). 
Methods: We analyzed 1,990 consecutive patients diagnosed with conventional PTC at surgery 
with preoperative Bethesda categories III, V, or VI. We determined the odds ratio (ORs) of the 
clinical and pathological variables associated with categories III and V, using category VI as the 
reference. 
Results: Category III and V PTCs had a smaller pathological tumor size (OR, 0.934 and OR, 
0.969, respectively) and less frequently had central lymph node metastasis (OR, 0.487 and OR, 
0.780, respectively) than category VI PTCs. Category III PTCs less frequently showed suspicious 
ultrasonographic features (OR, 0.296) than category VI PTCs, and category V PTCs less frequently 
had gross extrathyroidal extension, with borderline significance (OR, 0.643; P=0.059).
Conclusion: Conventional PTCs with a preoperative Bethesda category of III or V may less 
frequently exhibit poor prognostic factors than those with malignant cytology. 
Keywords: Thyroid nodule; Biopsy, fine-needle; Thyroid cancer, papillary; Ultrasonography
Received: July 31, 2017
Revised: November 20, 2017
Accepted: November 22, 2017
Correspondence to:
Hee Jung Moon, MD, PhD, Department 
of Radiology and Research Institute 
of Radiological Science, Severance 
Hospital, Yonsei University College of 
Medicine, 50 Yonsei-ro, Seodaemun-
gu, Seoul 03722, Korea
Tel. +82-2-2228-7400
Fax. +82-2-393-3035
E-mail: artemis4u@yuhs.ac
ORIGINAL ARTICLE
This is an Open Access article distributed under the 
terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/
licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in 
any medium, provided the original work is properly 
cited.
Copyright © 2018 Korean Society of 
Ultrasound in Medicine (KSUM)
How to cite this article: 
Park VY, Kim EK, Kwak JY, Yoon JH, Moon HJ. 
Associations between Bethesda categories 
and tumor characteristics of conventional 
papillary thyroid carcinoma. Ultrasonography. 
2018 Oct;37(4):323-329.
Introduction
The Bethesda System for Reporting Thyroid Cytopathology has been widely adopted following its 
proposal at a State-of-the-Science Conference in 2007, and has served as the primary method of 
interpreting thyroid fine-needle aspiration (FNA). It provides a 6-tiered standardized system with 
associated implied risks of malignancy for each diagnostic category [1]. Whereas thyroid nodules 
assigned to the Bethesda category VI (malignant) show cytomorphologic features conclusive for 
malignancy and have an implied risk of malignancy of 97%-99%, thyroid nodules assigned classified 
as Bethesda categories III (atypia of undetermined significance or follicular lesion of undetermined 
significance [AUS/FLUS]) and V (suspicious for malignancy) show cytomorphologic features inconclusive 
for malignancy, with implied risks of malignancy of 5%-15% and 60%-70%, respectively [1]. 
In addition to its original role as a diagnostic tool, recent research has reported possible 
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associations between Bethesda categories and pathological tumor 
characteristics [2-4]. Higher Bethesda categories at FNA have been 
associated with a larger pathological size, N stage, lymphovascular 
invasion, extrathyroidal extension, and aggressive variants of 
papillary thyroid carcinoma (PTC) [2-4]. However, the populations 
and methods have varied considerably across studies, including 
various histologic types of both thyroid malignancies and PTC and 
differing in whether Bethesda categories V and VI were combined 
[2-4]. Furthermore, the risks of poor pathological factors differ 
across histologic subtypes, and a previous study reported that there 
were no differences in pathologic features according to Bethesda 
categories when comparing PTCs of the same histologic subtype [3].
Therefore, the purpose of this study was to investigate the 
associations of Bethesda categories III, V, and VI with the clinical 
and pathological features of thyroid nodules surgically confirmed as 
conventional PTCs. 
Materials and Methods
Study Population 
Our institutional review board approved this retrospective study, 
and the requirement for informed consent was waived. From March 
2014 to October 2015, 2,173 consecutive patients underwent 
preoperative ultrasonography (US) and were confirmed to have 
conventional PTC at our institution. Among them, 80 patients 
with coexisting multiple tumors of other histologic subtypes were 
excluded. All the remaining 2,093 patients underwent US-FNA 
(n=2,018) or core biopsy (n=75) prior to surgery. Among the 2,018 
patients who underwent US-FNA, 1,990 had a Bethesda category 
III (n=98, 4.9%), V (n=730, 36.7%), or VI (n=1,162, 58.4%) 
lesion on preoperative US-FNA, which was performed either at our 
institution (n=335) or at an outside clinic (n=1,655). FNA slides that 
were performed at outside clinics were reviewed by the pathology 
department of our institution. These 1,990 patients (mean age, 
44.1 years; range, 10 to 79 years) constituted our study population. 
Of the 1,990 patients, 1,564 were women (mean age, 43.9 years; 
range, 10 to 79 years) and 426 were men (mean age, 44.7 years; 
range, 19 to 77 years). The median pathological tumor size was 9.6 
mm (range, 1 to 130 mm). 
US, US-FNA, and Cytological Diagnoses
At our institution, preoperative US for staging is routinely 
performed on patients for whom thyroid surgery is planned. US 
was performed by one of 15 board-certified radiologists with 
1-20 years of experience in thyroid imaging, using a 5- to 12-
MHz linear probe (EPIQ5 or iU22, Philips Medical Systems, Bothell, 
WA, USA). The US features and US assessment of thyroid nodules 
were prospectively recorded at the time of preoperative US. The 
internal components were classified as solid, predominantly 
solid (>50% solid for a mixed nodule), or predominantly cystic 
(>50% cystic for a mixed nodule). Echogenicity was classified as 
hyperechogenicity, isoechogenicity, hypoechogenicity, or marked 
hypoechogenicity [5]. Margins were classified as well-circumscribed, 
microlobulated, or irregular. Calcifications were categorized as 
microcalcifications, macrocalcifications, or no calcifications. Shape 
was classified as taller-than-wide (greater in its anteroposterior 
dimension than in its transverse dimension) or wider-than-tall. The 
US features that were considered suspicious for malignancy included 
marked hypoechogenicity, microlobulated or irregular margins, 
microcalcifications, and a taller-than-wide shape. Thyroid nodules 
that showed at least one of the above suspicious US features were 
assessed as suspicious, and nodules without suspicious US features 
were assessed as probably benign.
The Bethesda classification has been used at our institution 
since December 2009. Bethesda category VI is assigned whenever 
the cytomorphologic features are conclusive for malignancy [1]. 
Bethesda category V is assigned if only 1-2 characteristic features 
of PTC are present, if they are only focal and not widespread 
throughout the follicular cell population, or if the sample is sparsely 
cellular [1]. Bethesda category III is assigned when thyroid FNAs 
cannot be easily classified as benign, suspicious, or malignant [1]. 
During the study period, the cytological diagnosis was performed 
by one of five pathologists with at least 4 years of experience in 
thyroid cytopathology, who was arbitrarily assigned according to the 
hospital schedule. 
 
Surgical Procedure and Pathology 
Total or near-total thyroidectomy was performed in patients with 
multiple tumors, extrathyroidal invasion, or lymph node metastasis 
(LNM) upon preoperative evaluation or intraoperative findings. 
Central compartment neck dissection including the paratracheal, 
pretracheal, and prelaryngeal lymph nodes was routinely performed 
in all patients. Bilateral central compartment neck dissection 
was performed in patients who underwent total or near-total 
thyroidectomy and ipsilateral central compartment neck dissection 
was performed in patients who underwent hemithyroidectomy. 
Lateral compartment neck dissection was selectively performed 
in patients diagnosed with lateral LNM on preoperative US-FNA. 
If suspicious lymph nodes were found at the time of surgery, an 
intraoperative frozen biopsy was performed. In patients confirmed 
to have lateral LNM, the lateral neck compartments including levels 
2, 3, 4, and anterior 5 were dissected. Of the 1,990 patients with 
conventional PTC, 1,073 (53.9%) underwent total or near-total 
thyroidectomy and 917 (46.1%) underwent hemithyroidectomy. One 
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hundred and ninety-six patients (9.8%) underwent therapeutic lateral 
compartment neck dissection. We evaluated the pathological tumor 
size, multiplicity including both unilateral and bilateral tumor foci, 
and the presence of central and lateral LNM based on final surgical 
pathology reports. According to the eighth edition of the American 
Joint Committee on Cancer (AJCC) staging system [6], gross 
extrathyroidal extension was defined as extension involving major 
structures (strap muscles, subcutaneous soft tissue, larynx, trachea, 
esophagus, recurrent laryngeal nerve, prevertebral fascia, carotid 
artery, or mediastinal vessels) documented in the operative report. 
Statistical Analysis 
Clinical and pathological variables and US assessments were 
compared among Bethesda categories III, V, and VI using the chi-
square test for categorical variables and the analysis of variance test 
for continuous variables. Post hoc pairwise analysis was performed 
with the Bonferroni method for multiple comparison adjustment. To 
assess the associations between Bethesda categories and clinical 
variables, pathological variables, and US assessments, multinomial 
logistic regression analysis was carried out using Bethesda category 
VI as the reference. Variables that had a P-value of <0.05 in the 
univariate multinomial logistic regression analysis were included in a 
multivariable multinomial logistic regression model to assess whether 
they had independent associations with the Bethesda categories. The 
statistical analysis was performed using SAS ver. 9.4 (SAS Inc., Cary, 
NC, USA) and SPSS ver. 23.0 (IBM Corp., Armonk, NY, USA).
Results
Of the 1,990 patients with conventional PTC, 127 (6.4%) had gross 
Table 1. Comparison of clinical and pathologic characteristics among Bethesda categories III, V, and VI in 1,990 patients with 
conventional papillary thyroid carcinoma 
Variable
Bethesda classification
Overall 
P-valuea)
Post hoc pairwise P-values with 
Bonferroni correctionb)
Category III (1) 
(n=98)
Category V (2) 
(n=730)
Category VI (3) 
(n=1,162)
(1) vs. (2) (1) vs. (3) (2) vs. (3)
Age (yr) 46.5±12.7 44.0±11.7 43.9±12.0 0.118
Sex 0.371 >0.999 >0.999 >0.999
   Male 72 (73.5) 581 (79.6) 911 (78.4)
   Female 26 (26.5) 149 (20.4) 251 (21.6)
US assessment 0.019 0.114 0.028 >0.999
   Suspicious 91 (92.9) 709 (97.1) 1,137 (97.8)
   Probably benign 7 (7.1) 21 (2.9) 25 (2.2)
Tumor size (mm) 7.6±5.1 8.6±6.1 10.4±8.0 <0.001c)
Gross extrathyroidal extension <0.001 >0.999 0.057 <0.001
   Yes 2 (2.0) 28 (3.8) 97 (8.3)
   No 96 (98.0) 702 (96.2) 1,065 (91.7)
Central lymph node metastasis <0.001 0.131 <0.001 <0.001
   Yes 23 (23.5) 250 (34.2) 511 (44.0)
   No 75 (76.5) 480 (65.8) 651 (56.0)
Lateral lymph node metastasis 0.003 >0.999 0.664 0.004
   Yes 7 (7.1) 52 (7.1) 137 (11.8)
   No 91 (92.9) 678 (92.9) 1,025 (88.2)
Multiplicity 0.103 >0.999 >0.999 0.138
   Yes 29 (29.6) 217 (29.7) 398 (34.3)
   No 69 (70.4) 513 (70.3) 764 (65.7)
Values are presented as mean±standard deviation or number (%). 
US, ultrasonography; ANOVA, analysis of variance.
a)Calculated using the chi-square test or the Fisher exact test for categorical variables and ANOVA for continuous variables. b)Calculated using the chi-square test or the Fisher 
exact test for categorical variables and the t test for continuous variables. The post hoc pairwise P-values with the Bonferroni correction were calculated by multiplying the 
pairwise raw P-values by 3, which is the number of comparisons made. c)Significant differences were seen between categories III and VI and between categories V and VI, using 
ANOVA with Bonferroni post hoc analysis.
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extrathyroidal extension, 784 (39.4%) had central LNM, 196 (9.8%) 
had lateral LNM, and 644 (32.4%) had multiple tumors. Category 
VI PTCs had a higher proportion of nodules with suspicious US 
features than category III PTCs, a larger pathological tumor size, a 
higher proportion of nodules with gross extrathyroidal extension 
and central LNM than category III and category V PTCs, and a higher 
proportion of lateral LNM than category V PTCs (Table 1). 
In the univariate multinomial logistic regression analysis, patients 
with category III PTCs were older than those with category VI PTCs 
(odds ratio [OR], 1.018; 95% confidence interval [CI], 1.001 to 
1.035). Both category III PTCs and category V PTCs had a smaller 
pathological tumor size, less frequently had central LNM, and less 
frequently had gross extrathyroidal extension than category VI PTCs 
(Table 2). Category III PTCs less frequently showed suspicious US 
features (OR, 0.286; 95% CI, 0.120 to 0.679) and category V PTCs 
less frequently had lateral LNM (OR, 0.574; 95% CI, 0.411 to 0.801) 
and multiple tumors (OR, 0.812; 95% CI, 0.665 to 0.991) than 
category VI PTCs (Figs. 1, 2). 
In the multivariable multinomial logistic regression analysis, 
category III and category V PTCs had a smaller pathological tumor 
size (category III: OR, 0.934; 95% CI, 0.889 to 0.981; category V: 
OR, 0.969; 95% CI, 0.952 to 0.986) and less frequently had central 
LNM (category III: OR, 0.487; 95% CI, 0.287 to 0.827; category V: 
OR, 0.780; 95% CI, 0.633 to 0.962) than category VI PTCs (Table 2). 
Category III PTCs less frequently showed suspicious US features (OR, 
0.296; 95% CI, 0.121 to 0.720) than category VI PTCs. Lateral LNM 
and gross extrathyroidal extension were not significantly associated 
with Bethesda categories in the multivariable analysis, although 
Table 2. Univariate and multivariable multinomial logistic regression analysis of 1,990 conventional papillary thyroid carcinomas 
using category VI as the reference
Variable
Univariate multinomial Multivariable multinomial
Category III 
(n=98)
OR (95% CI)
P-value
Category V 
(n=730)
OR (95% CI)
P-value
Category III 
(n=98)
OR (95% CI)
P-value
Category V 
(n=730)
OR (95% CI)
P-value
Age (yr) 1.018 
(1.001-1.035)
0.040 1.001 
(0.993-1.008)
0.851 1.013 
(0.995-1.031)
0.159 0.998 
(0.990-1.006)
0.626
Sex 0.259 0.537 0.118 0.902
    Male 1.311 
(0.820-2.097)
0.931 
(0.741-1.169)
1.469 
(0.907-2.380)
1.015 
(0.803-1.282)
   Female 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.)
US assessment 0.005 0.320 0.007 0.312
   Suspicious 0.286 
(0.120-0.679)
0.742 
(0.412-1.336)
0.296 
(0.121-0.720)
0.734 
(0.403-1.336)
   Probably benign 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.)
Tumor size (mm) 0.917 
(0.875-0.962)
<0.001 0.957 
(0.942-0.973)
<0.001 0.934 
(0.889-0.981)
0.007 0.969 
(0.952-0.986)
<0.001
Gross ETE 0.041 <0.001 0.261 0.059
   Yes 0.229 
(0.056-0.943)
0.438 
(0.285-0.674)
0.432 
(0.100-1.869)
0.643 
(0.406-1.017)
   No 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.)
Central LNM <0.001 <0.001 0.008 0.020
   Yes 0.391 
(0.241-0.632)
0.664 
(0.548-0.804)
0.487 
(0.287-0.827)
0.780 
(0.633-0.962)
   No 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.)
Lateral LNM 0.170 0.001 0.468 0.456
   Yes 0.576 
(0.261-1.267)
0.574 
(0.411-0.801)
1.383 
(0.577-3.312)
0.870 
(0.603-1.255)
   No 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.)
Multiplicity 0.350 0.041 0.785 0.375
   Yes 0.807 
(0.514-1.266)
0.812 
(0.665-0.991)
0.937 
(0.588-1.494)
0.911 
(0.741-1.120)
   No 1 (Ref.) 1 (Ref.) 1 (Ref.) 1 (Ref.)
OR, odds ratio; CI, confidence interval; US, ultrasonography; ETE, extrathyroidal extension; LNM, lymph node metastasis; Ref., Reference.
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category V PTCs less frequently had gross extrathyroidal extension, 
with borderline significance (OR, 0.643; 95% CI, 0.406 to 1.017; 
P=0.059) (Fig. 3).
Discussion
We aimed to investigate the associations of Bethesda categories 
with the clinical and pathological features of conventional PTCs, 
using category VI as the reference. Compared with category VI PTCs, 
both category III and V PTCs had a smaller pathological tumor size 
and less frequently had central LNM. In addition, category III PTCs 
less frequently showed suspicious US features, and category V PTCs 
less frequently had gross extrathyroidal extension than category VI 
PTCs, with borderline significance (P=0.059). Our results show that 
the preoperative Bethesda categories provided valuable information 
regarding the pathological features of conventional PTC. 
Fig. 1. A 32-year-old woman with conventional papillary thyroid carcinoma that was initially diagnosed as Bethesda category III (atypia 
of undetermined significance or follicular lesion of undetermined significance) by fine-needle aspiration. 
A, B. Ultrasonography (A, transverse; B, longitudinal view) shows an isoechoic solid mass in the right thyroid gland with no suspicious 
ultrasonographic features (arrows). The pathologic tumor size was 16 mm, and there was no evidence of lymph node metastasis or gross 
extrathyroidal extension at surgery. 
A B
Fig. 2. A 46-year-old woman with conventional papillary thyroid carcinoma that was initially diagnosed as Bethesda category V 
(suspicious for malignancy) by fine-needle aspiration. 
A, B. Ultrasonography (A, transverse; B, longitudinal view) shows a hypoechoic, irregular, non-parallel mass with spiculated margins in the left 
thyroid gland (arrows). The pathologic tumor size was 10 mm, and there was no evidence of lymph node metastasis or gross extrathyroidal 
extension at surgery. 
A B
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suspicious for a follicular neoplasm in the analyses [2-4,12]. When 
performing subgroup analysis according to the histologic subtype, 
a study reported no difference in any aggressive features according 
to Bethesda categories [3]. Another recent study on conventional 
PTC reported that the Bethesda categories were predictive of 
extrathyroidal extension and lymph node metastasis, although it 
included both minimal and extensive extrathyroidal extension and 
did not differentiate between central and lateral LNM [13]. Our 
results were largely consistent with previous studies, showing that 
category III and category V PTCs less frequently exhibited central 
LNM and were smaller than category VI PTCs. 
According to the revised AJCC eighth edition TNM classification 
and staging system, minimal extrathyroidal extension has been 
eliminated from the T criteria, with only gross extrathyroidal 
extension influencing the T category and stage groups [6]. This 
is primarily based on data indicating that minimal/microscopic 
extrathyroidal extension was not associated with survival outcomes, 
especially in small differentiated thyroid cancers [14-17]. In our 
study, category V PTCs less frequently exhibited gross extrathyroidal 
extension than category VI PTCs, although with borderline 
significance (P=0.059). In addition, the presence of malignant-
appearing US features has been reported to be associated with 
recurrence or poor prognostic factors in patients with conventional 
PTC [18,19]. In our study, category III PTCs less frequently showed 
suspicious US features than category VI PTCs. Therefore, our results 
suggest that Bethesda category III or V PTCs are less likely to be 
associated with poor prognostic factors. 
Malignant thyroid FNA diagnoses account for 4%-8% of all 
thyroid FNAs, of which the majority are PTCs [7]. Although certain 
characteristic nuclear alterations help define PTC, none of them 
are diagnostic in isolation or in a low frequency. The minimum 
criteria and number of altered cells necessary for an unequivocal 
diagnosis are uncertain, and cases that have some features of 
PTC but fall short of an unequivocal diagnosis are interpreted as 
category III or V, depending on the quality and quantity of changes 
and the reviewer’s level of suspicion for PTC [7]. Nodule size has 
been reported to be an independent factor affecting paucicellular 
aspirates, and therefore, smaller conventional PTCs may result in 
aspirates with low cellularity and be classified as category III or V [8]. 
In addition, larger tumors have been associated with the presence of 
central LNM, which may partly explain the associations of Bethesda 
categories with central LNM in our study [9-11].
Previous studies have focused on investigating associations 
between Bethesda categories and aggressive characteristics 
of thyroid cancer, but have varied considerably in study design 
and results [2-4,12,13]. Category VI cytology results have been 
consistently associated with high-risk histologic subtypes of PTC, 
whereas follicular variants of PTC predominate in category III cancers 
[2-4,12]. Those studies have also reported that a higher Bethesda 
category was associated with aggressive tumor characteristics, 
including a higher AJCC T and N category, lymphovascular invasion, 
extrathyroidal extension, and lymph node metastases. However, 
various histologic subtypes of PTC were included, which is reflected 
by the inclusion of the Bethesda category of follicular neoplasm or 
Fig. 3. A 24-year-old women with conventional papillary thyroid carcinoma that was diagnosed as Bethesda category VI (malignant) by 
fine-needle aspiration. 
A, B. Ultrasonography (A, transverse; B, longitudinal view) shows a hypoechoic, irregular mass with gross invasion of the strap muscle (arrows). 
At surgery, central lymph node metastasis was also diagnosed. 
A B
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There are several limitations to our study. First, this was a 
retrospective study conducted at a single institution. Second, we 
only included patients who underwent surgery at our institution, 
and therefore selection bias was inevitable. Third, preoperative US 
and US-FNA were performed by a large number of radiologists, 
thus causing potential interobserver variability. However, this is an 
inherent part of daily clinical practice and would be present at any 
other institution. Fourth, Bethesda category III (AUS/FLUS) is affected 
by various factors, including FNA technique and specimen quality, as 
well as intrinsic tumor characteristics.  
In conclusion, the Bethesda categories may be associated with 
prognostic factors in conventional PTC. Conventional PTCs classified 
as preoperative Bethesda category III or V may less frequently 
exhibit central LNM and have a smaller pathological tumor size than 
those with malignant cytology. 
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